NASDAQ: OCGN
Ocugen Inc Stock Ownership - Who owns Ocugen?

Insider buying vs selling

Have Ocugen Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Shankar MusunuriChief Executive Officer2025-01-03177,146$0.89
$158.37kSell
Arun UpadhyayChief Scientific Officer Head of Research Development and Medical2025-01-0341,633$0.89
$37.22kSell
Prabhavathi FernandesDirector2024-11-2610,000$0.91
$9.09kBuy
Kirsten CastilloDirector2024-11-2225,000$0.91
$22.85kBuy
Arun UpadhyayChief Scientific Officer Head of Research Development and Medical2024-09-16842$1.17
$985.14Sell

1 of 1

OCGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when OCGN insiders and whales buy or sell their stock.

OCGN Shareholders

What type of owners hold Ocugen Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc6.70%19,573,112$19.57MInstitution
Vanguard Group Inc5.71%16,683,113$16.68MInstitution
Geode Capital Management LLC2.36%6,888,821$6.89MInstitution
State Street Corp2.03%5,932,041$5.93MInstitution
Michael 1. Lewis1.90%5,548,103$5.55MInsider
Wilmslow Estates Ltd1.80%5,258,859$5.26MInsider
Randal J. Kirk1.50%4,382,936$4.38MInsider
Ubs Group Ag1.50%4,367,780$4.37MInstitution
Gmt Capital Corp1.42%4,153,798$4.15MInstitution
Shankar Musunuri1.41%4,123,321$4.12MInsider

1 of 3

OCGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OCGN26.27%10.45%Net Selling
NMRA29.21%70.79%Net Selling
ADCT55.30%43.42%Net BuyingNet Selling
HRTX51.09%48.91%
OLMA71.66%28.34%Net Selling

Ocugen Stock Ownership FAQ

Who owns Ocugen?

Ocugen (NASDAQ: OCGN) is owned by 26.27% institutional shareholders, 10.45% Ocugen insiders, and 63.28% retail investors. Michael 1. Lewis is the largest individual Ocugen shareholder, owning 5.55M shares representing 1.90% of the company. Michael 1. Lewis's Ocugen shares are currently valued at $5.66M.

If you're new to stock investing, here's how to buy Ocugen stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.